Clinical trial
Impact of B-lines-guided Intensive Heart Failure Management on Outcome of Discharged Heart Failure Patients With Residual B-lines
NCT05035459 is registered in ClinicalTrials.gov with Xiangtan Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of B-lines-guided Intensive Heart Failure Management on Outcome of Discharged Heart Failure Patients With Residual B-lines
- Lead sponsor
- Xiangtan Central Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 25, 2022
- Completion date
- August 25, 2024
- Enrollment
- 320 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, lung ultrasound